Galecto (GLTO) News Today $3.53 +0.06 (+1.61%) Closing price 07/11/2025 03:55 PM EasternExtended Trading$3.52 0.00 (-0.03%) As of 07/11/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GLTO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Galecto (NASDAQ:GLTO) Trading 2.2% Higher - Time to Buy?July 9 at 2:33 AM | americanbankingnews.comGalecto, Inc. (GLTO) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | sg.finance.yahoo.comGalecto, Inc. Reports First Quarter 2025 Financial Results and Progress on AML Treatment DevelopmentMay 10, 2025 | nasdaq.comGalecto, Inc.: Galecto Reports First Quarter 2025 Operating and Financial ResultsMay 9, 2025 | finanznachrichten.deGalecto Reports First Quarter 2025 Operating and Financial ResultsMay 8, 2025 | globenewswire.comGalecto (GLTO)April 12, 2025 | es.investing.comGalecto, Inc. Focuses on Oncology and Liver DiseasesApril 3, 2025 | tipranks.comGalecto trading halted, volatility trading pauseMarch 26, 2025 | markets.businessinsider.comGalecto Reports Full-Year 2024 Financial ResultsMarch 19, 2025 | globenewswire.comGalecto stock hits 52-week low at $4.39 amid market challengesFebruary 12, 2025 | msn.comGalecto to Participate in Upcoming Investor ConferencesFebruary 6, 2025 | globenewswire.comGalecto (NASDAQ:GLTO) Stock, Option ChainNovember 15, 2024 | benzinga.comGalecto, Inc. Announces Strategic Shift and Financial OverviewNovember 2, 2024 | markets.businessinsider.comGalecto, Inc.’s Strategic Shift to Oncology and Liver Diseases: Navigating Risks and OpportunitiesNovember 2, 2024 | tipranks.comGalecto reports Q3 EPS ($3.39) vs ($7.50)November 1, 2024 | msn.comGalecto Reports Third Quarter 2024 Financial ResultsNovember 1, 2024 | globenewswire.comGalecto price target raised to $10 from $9 at OppenheimerOctober 18, 2024 | finance.yahoo.comGalecto incorpora a la Dra. Amy Wechsler a su Consejo de AdministraciónOctober 17, 2024 | es.investing.comOppenheimer Sticks to Its Buy Rating for Galecto (GLTO)October 17, 2024 | markets.businessinsider.comGalecto (NASDAQ:GLTO) Price Target Increased to $10.00 by Analysts at OppenheimerOctober 17, 2024 | marketbeat.comGalecto Strengthens Board of Directors with Appointment of Dr. Amy WechslerOctober 15, 2024 | globenewswire.comGalecto To Focus On Clinical Stage Compound GB1211; Obtains Global Rights To BRM-1420October 7, 2024 | markets.businessinsider.comWhy Galecto (GLTO) Shares Are Down 27% TodayOctober 7, 2024 | msn.comGalecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge MedicinesOctober 7, 2024 | globenewswire.comLas acciones de Galecto tocan un máximo de 52 semanas a 11,67 USD en medio de las fluctuaciones del mercadoAugust 31, 2024 | es.investing.comGalecto Announces Reverse Stock SplitAugust 28, 2024 | globenewswire.comMinerva Neurosciences Inc (4MNA.BE)July 19, 2024 | finance.yahoo.comGLTO Stock Earnings: Galecto Beats EPS for Q1 2024May 3, 2024 | investorplace.comGalecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with PembrolizumabMay 1, 2024 | globenewswire.com6 Stocks Positioned to Soar as Investors Focus on MASHApril 22, 2024 | theglobeandmail.comGLTO Stock Earnings: Galecto Beats EPS for Q4 2023March 15, 2024 | msn.comGalecto Inc.February 16, 2024 | thestreet.comGalecto, Inc. (GLTO) Upgraded to Strong Buy: What Does It Mean for the Stock?February 14, 2024 | finance.yahoo.comWhat Makes Galecto, Inc. (GLTO) a New Strong Buy StockJanuary 9, 2024 | finance.yahoo.comGalecto, Inc.: Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with MyelofibrosisDecember 23, 2023 | finanznachrichten.deNike, AAR And 3 Stocks To Watch Heading Into FridayDecember 22, 2023 | msn.comTopline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with MyelofibrosisDecember 21, 2023 | finance.yahoo.comGalecto Presents Updated Clinical Data at ESMO Congress 2023 and Provides Update on Phase 1b/2a GALLANT-1 TrialOctober 23, 2023 | finance.yahoo.comGalecto (GLTO) Price Target Increased by 13.16% to 5.48October 5, 2023 | msn.comGalecto, Inc.: Galecto Announces Plans to Explore Strategic AlternativesOctober 1, 2023 | finanznachrichten.deHC Wainwright & Co. Downgrades Galecto (GLTO)September 29, 2023 | msn.comWeeks after dropping lung disease drug, Galecto lays off most of staff, explores saleSeptember 27, 2023 | bizjournals.comGalecto Announces Plans to Explore Strategic AlternativesSeptember 26, 2023 | finance.yahoo.comGalecto Biotech Collapse: Opportunity For Galectin TherapeuticsSeptember 14, 2023 | msn.comGalecto to Present at Investor Conferences in SeptemberAugust 31, 2023 | finance.yahoo.comHC Wainwright & Co. Maintains Galecto (GLTO) Buy RecommendationAugust 22, 2023 | msn.comExpert Ratings for GalectoAugust 21, 2023 | markets.businessinsider.comBiotech Stock Roundup: GLTO Plunges on Setback, BLUE Offers Updates & MoreAugust 17, 2023 | finance.yahoo.comGalecto Ends Development of Lead Candidate After IPF Study Failure >GLTOAugust 16, 2023 | marketwatch.comGalecto (GLTO) Down 71% as Lung Disease Candidate FailsAugust 16, 2023 | finance.yahoo.com Get Galecto News Delivered to You Automatically Sign up to receive the latest news and ratings for GLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address GLTO Media Mentions By Week GLTO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLTO News Sentiment▼-0.031.00▲Average Medical News Sentiment GLTO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLTO Articles This Week▼40▲GLTO Articles Average Week Get Galecto News Delivered to You Automatically Sign up to receive the latest news and ratings for GLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cingulate News Today Marker Therapeutics News Today BioVie News Today Q32 Bio News Today Mannatech News Today ProPhase Labs News Today Reviva Pharmaceuticals News Today Carisma Therapeutics News Today Lipocine News Today Gelteq News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLTO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galecto With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
